Webinar

Life Reclaimed: APPs Guiding Patients with Ulcerative Colitis Through Symptoms of Bowel Urgency

Launch Date
04/09/2024 at 12:00 am EST
Credit Amount
1
Credit Expires
04/09/2025

Faculty

Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Moderator
Assistant Professor
Johns Hopkins University School of Medicine
Department of Medicine, Division of Gastroenterology & Hepatology
Baltimore, MD
Professor
University of Delaware School of Nursing
Newark, DE
Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE, FCCF
Professor of Clinical Medicine, Houston Methodist Academic Institute
Professor of Clinical Medicine, Weill Cornell Medical College
Adjunct Professor of Clinical Education, Texas A&M University, College of Medicine
Director, Gastroenterology Fellowship Program, Houston Methodist
Distinguished Professor and Director, Underwood Center - Fondren Inflammatory Bowel Disease Program
Houston Methodist Gastroenterology Associates
Houston, TX
Kimberly Kearns, MS, APRN, ANP-BC
Nurse Practitioner
Clinical Supervisor of Gastroenterology Advanced Practice Providers
DULY Health and Care
Hoffman Estates, IL
Co-Chair for the Crohn's & Colitis Foundation Diversity & Inclusion Committee
Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

More than 80% of patients with ulcerative colitis (UC), including those receiving treatment, experience bowel urgency. This symptom dramatically impacts patient quality of life (QoL) and can lead to depression, social isolation, disruption with work, interference with relationships, and fatigue. Bowel urgency has not been widely incorporated into clinical assessment indices or clinical trial endpoints for UC, despite being a pivotal symptom influencing patient health-related QoL and a potential indicator of uncontrolled intestinal inflammation. To change practice, clinicians must implement patient-centered strategies for discussing symptoms of bowel urgency and devising clinical treatment plans that utilize current and new therapies while being knowledgeable about endpoints used in clinical trials and updated guideline-based definitions of clinical remission.

In this CME Outfitters recorded webcast, leading clinical experts will help prepare learners to discuss, assess, and address bowel urgency in patients with UC, and will provide insight into the effects of new and emerging therapies.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Evaluate bowel urgency as one of the most life-disrupting and isolating symptoms experienced by patients with UC
  • Incorporate assessment of bowel urgency into routine care of patients with UC, including endpoints used in clinical trials and updated guideline-based definitions of clinical remission
  • Develop comprehensive management strategies in bio-naïve and bio-experienced patients with moderate-to-severe UC associated with improvement in symptoms of bowel urgency

Financial Support

This activity is supported by an educational grant from Lilly.

Target Audience

Primary: Gastroenterology nurse practitioners (NPs) and physician associates (PAs)
Secondary: RNs and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education Credit for learning and change.

Nurses (ANCC) 1.0

This activity is designated for 1.00 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.00 contact hours ( 0.1 CEUs) of continuing pharmacy credit (JA0007185-0000-24-024-H01-P).

PAs (AAPA) 1.00

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 04/09/2025. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Declaration

Dr. Dudley-Brown reports the following financial relationships:

Advisory Board: Bristol Myers Squibb Company and Pfizer Inc.

Consultant: AbbVie Inc. and Lilly

Dr. Abraham reports the following financial relationships:

Consultant: AbbVie Inc.; Bristol Myers Squibb Company; Celltrion Inc.; Fresnius Kabi; Janssen Pharmaceuticals, Inc.; Lilly; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Speakers Bureau: AbbVie Inc.; Bristol Myers Squibb Company; Janssen Pharmaceuticals, Inc.; Lilly; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Ms. Kearns reports the following financial relationships:

Advisory Board: Ardelyx (IBS); Bristol Myers Squibb Company (IBD); Eli Lilly and Company (IBD); Janssen Pharmaceuticals, Inc. (IBD); Pfizer Inc. (IBD); Phathom Pharmaceuticals (EE); and Salix Pharmaceuticals (IBS/CIC)

Speakers Bureau: Eli Lilly and Company (IBD); Janssen Pharmaceuticals, Inc. (IBD); Salix Pharmaceuticals (IBS/CIC); and Takeda Pharmaceuticals U.S.A., Inc. (IBD)

The following individuals have no financial relationships to disclose: 

Rebecca Vargas-Jackson, MD  (Peer Reviewer)
Michael Franks, APRN, AGACNP-BC, FNP-BC (Peer Reviewer)
Amanda K. Smith, PA-C (Peer Reviewer)
Sarah Rojas (Patient Planner)
Susan Perry (Planning Committee)
Kasey Brandt, PharmD (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

WCV-082-040924-11

Life Reclaimed: APPs Guiding Patients with Ulcerative Colitis Through Symptoms of Bowel Urgency
Event Date: 04/09/2024 at 12:00 am EST
Begin